Steven Schachter
RADx Chief; Professor
Harvard Medical School
Lisa Suennen
Lead, Digital & Technology Group
Manatt Ventures
Sir Mark Caulfield
CEO
Barts Life Sciences
Jessica L. Mega
Co-Founder & CSO
Verily
Robert C. Green
Director, G2P Program
Brigham and Women's Hospital
Cecilia Schott
Head, Global Precision Medicine
Novartis
Simon Gregory
Director, Molecular Genomics Core
Duke Molecular Physiology Institute
Ruth March
SVP & Head, Precision Medicine
AstraZeneca
Howard I. Scher
Head, Biomarker Development
Memorial Sloan Kettering Cancer Center
Mara Aspinall
Managing Director
BlueStone Venture Partners
Tom Miller
Founder, Managing Partner
GreyBird Ventures
Lara Jehi
Chief Research Information Officer
Cleveland Clinic
Vincent Mikol
Head, Translational Sciences,
Sanofi
Megan Mahoney
Chief of Staff
Stanford Health Care
Michael Snyder
Director, Genomics & Personalized Medicine
Stanford Univ
Esther Babady
Head, Clinical Microbiology
Memorial Sloan Kettering Cancer Center
Jürgen Scheuenpflug
Global Head, Biomarkers and Companion Diagnostics
Merck
Ellie Corigliano
Head, Precision Medicine and Diagnostics
GlaxoSmithKline
Dan Theodorescu
Director
Cedars-Sinai Cancer Center
Razelle Kurzrock
Chair
Worldwide Innovative Network (WIN) for Personalized Cancer Therapy
Nathan D. Price
CEO
Onegevity
Shirin Khambata Ford
Head, Precision Medicine
Daiichi Sankyo
Adam Dakin
Managing Director, Healthtech
Dreamit Ventures
Pia Davidsson
Head, Experimental Medicine
AstraZeneca
John Quackenbush
Chair, Biostatistics
Harvard